A Well-known Weight-loss Drug Also Reduces The Risk of Dementia
Oxford: Novo Nordisk Pharma’s leading weight loss drug Ozempic has also been linked to a lower risk of dementia and other mental illnesses in a recent study. In a study conducted by experts at Oxford University, people who took Ozampic had a 48% lower risk of dementia after one year than those who took sitagliptin,